Correlation Between Eliem Therapeutics and GeoVax Labs
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and GeoVax Labs, you can compare the effects of market volatilities on Eliem Therapeutics and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and GeoVax Labs.
Diversification Opportunities for Eliem Therapeutics and GeoVax Labs
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eliem and GeoVax is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and GeoVax Labs go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and GeoVax Labs
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the GeoVax Labs. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 3.12 times less risky than GeoVax Labs. The stock trades about -0.29 of its potential returns per unit of risk. The GeoVax Labs is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 199.00 in GeoVax Labs on August 29, 2024 and sell it today you would earn a total of 71.00 from holding GeoVax Labs or generate 35.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 90.91% |
| Values | Daily Returns |
Eliem Therapeutics vs. GeoVax Labs
Performance |
| Timeline |
| Eliem Therapeutics |
| GeoVax Labs |
Eliem Therapeutics and GeoVax Labs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and GeoVax Labs
The main advantage of trading using opposite Eliem Therapeutics and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| GeoVax Labs vs. Eliem Therapeutics | GeoVax Labs vs. Scpharmaceuticals | GeoVax Labs vs. Milestone Pharmaceuticals | GeoVax Labs vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |